• Explore /
  • Poster
  • / Deciphering the prognostic value of <em>FGFR2b/2c</em> isoform expression levels in advanced esophagogastric cancer through whole-transcriptome sequencing.

Deciphering the prognostic value of FGFR2b/2c isoform expression levels in advanced esophagogastric cancer through whole-transcriptome sequencing.

Abstract Poster

Authors

null

Tadayoshi Hashimoto

Department of Gastroenterology and Gastrointestinal Oncology/Translational Research Support Office, National Cancer Center Hospital East, Kashiwa, Japan

Tadayoshi Hashimoto , Naoko Iida , Yoshiaki Nakamura , Saori Mishima , Daisuke Kotani , Akihito Kawazoe , Izuma Nakayama , Yasutoshi Kuboki , Taro Shibuki , Mitsuho Imai , Takao Fujisawa , Hideaki Bando , Takayuki Yoshino , Kohei Shitara

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Breakthrough

Session Type

Poster Session

Session Title

Poster Session A

Track

Gastrointestinal Cancer,Central Nervous System Tumors,Developmental Therapeutics,Genitourinary Cancer,Quality of Care,Healthcare Equity and Access to Care,Population Health,Viral-Mediated Malignancies

Sub Track

Advanced Disease

Citation

J Clin Oncol 42, 2024 (suppl 23; abstr 53)

DOI

10.1200/JCO.2024.42.23_suppl.53

Abstract #

53

Poster Bd #

C5

Abstract Disclosures

Similar Posters

Poster

2017 Gastrointestinal Cancers Symposium

Biomarker studies in a phase I trial of DKN-01 in advanced esophageal cancer.

Biomarker studies in a phase I trial of DKN-01 in advanced esophageal cancer.

First Author: John H. Strickler

First Author: Tareq Al Baghdadi

First Author: Tadayoshi Hashimoto

First Author: Tian Tian